Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mexiletine for the Treatment of Muscle Cramps in ALS

This study has been completed.
University of California, Davis
ALS Association
Information provided by (Responsible Party):
Bjorn Oskarsson, MD, University of California, Davis Identifier:
First received: March 6, 2013
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)